Ryboquin raises £1.8m

Scottish drug developer Ryboquin has raised a further £1.8m to progress development of its gene therapy treatment for cancer. Backers of the Selkirk-based company include existing investors such as Borders business angel group TRI Capital and the Scottish Investment Bank.

Knowledge Hub

Archives

Calendar

LINC Scotland is the national association for business angels in Scotland, with a membership which includes many active individual investors and most of the main angel groups or syndicates. We represent our members at government level in Edinburgh, London and Brussels.

Opening Hours

Please note this website requires cookies in order to function correctly, they do not store any specific information about you personally. By continuing to use this website you are giving consent to cookies being used. Find out more.